First Dallas Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,350
Closed -$354K 120
2024
Q4
$354K Sell
13,350
-9,250
-41% -$251K 0.14% 101
2024
Q3
$654K Sell
22,600
-2,700
-11% -$78.8K 0.27% 65
2024
Q2
$708K Buy
25,300
+5,100
+25% +$140K 0.31% 61
2024
Q1
$561K Buy
20,200
+5,350
+36% +$148K 0.26% 81
2023
Q4
$428K Buy
+14,850
New +$449K 0.22% 87
2023
Q1
Sell
-9,523
Closed -$488K 123
2022
Q4
$488K Sell
9,523
-12,720
-57% -$610K 0.29% 74
2022
Q3
$973K Sell
22,243
-16,349
-42% -$794K 0.67% 46
2022
Q2
$2.02M Sell
38,592
-11,262
-23% -$574K 1.36% 19
2022
Q1
$2.58M Sell
49,854
-128
-0.3% -$6.64K 1.46% 19
2021
Q4
$2.95M Buy
49,982
+7,363
+17% +$365K 1.94% 11
2021
Q3
$1.83M Buy
+42,619
New +$1.89M 1.27% 23
2018
Q1
Sell
-3,436
Closed -$118K 130
2017
Q4
$118K Buy
+3,436
New +$117K 0.08% 136
2015
Q3
Sell
-7,399
Closed -$235K 110
2015
Q2
$235K Buy
+7,399
New +$241K 0.17% 91

Other funds holding PFE

First Dallas Securities's PFE Position: Q1 2025 in Review

First Dallas Securities sold out of Pfizer (PFE) in Q1 2025, closing a stake of 13,350 shares — an estimated $354K sold.

First Dallas Securities first reported a position in PFE in Q2 2015 and held it in 13 quarters. The position peaked at $2.95M in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • First Dallas Securities reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • First Dallas Securities sold 13,350 Pfizer shares in Q1 2025, an estimated $354K.
  • First Dallas Securities first reported a position in Pfizer in Q2 2015 and held it in 13 quarters.
  • First Dallas Securities's Pfizer position peaked at $2.95M in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on First Dallas Securities's 13F filing for Q1 2025, filed 16 May 2025.